| Identification | |
| Name: | Tenatoprazole |
| Synonyms: | 1H-Imidazo[4,5-b]pyridine,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- (9CI);2-[2-((4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl]-5-methoxyimidazo[4,5-b]pyridine;5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-imidazo[4,5-b]pyridine;TU 199;3H-Imidazo[4,5-b]pyridine,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-; |
| CAS: | 113712-98-4 |
| Molecular Formula: | C16H18N4O3S |
| Molecular Weight: | 346.4 |
| InChI: | InChI=1/C16H18N4O3S/c1-9-7-17-12(10(2)14(9)23-4)8-24(21)16-18-11-5-6-13(22-3)19-15(11)20-16/h5-7H,8H2,1-4H3,(H,18,19,20) |
| Molecular Structure: | ![(C16H18N4O3S) 1H-Imidazo[4,5-b]pyridine,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- (9CI);...](https://img.guidechem.com/casimg/113712-98-4.gif) |
| Properties | |
| Density: | 1.41 g/cm3 |
| Refractive index: | 1.673 |
| Appearance: | white crystalline powder |
| Specification: |
?Tenatoprazole (CAS NO.113712-98-4) is also named as (+-)-5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1H-imidazo(4,5-b)pyridine ; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-imidazo(4,5-b)pyridine ; Protop ; Tu 199 ; UNII-RE0689TX2K ; Ulsacare?; 1H-Imidazo(4,5-b)pyridine, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)- .?Tenatoprazole (CAS NO.113712-98-4) is?white crystalline powder. It is an imidazopyridine derivative and has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors. |
| Usage: | A proton pump inhibitor for reduction and/or prevention of gastrointestinal disorders |
| Safety Data | |
| Hazard Symbols |
Xn: Harmful
|
 |
|
